Sensus Healthcare Q2 FY26 net loss widens to $8.75 million; revenue drops 68.5% to $2.29 million - SRTS News | RalliesSensus Healthcare Q2 FY26 net loss widens to $8.75 million; revenue drops 68.5% to $2.29 million
S
SRTS• Timing shift and pipeline update
- Revenue recognition on eight purchased units shifted to Q3 due to financing approval timing; management said demand and execution held up.
- Pipeline strengthened following CPT code implementation; CMS proposed a 26% increase in the hospital-based SRT delivery code.
Quarterly results weaken as revenue falls
- Sensus Healthcare Q2 2026 revenue fell 68.5% to $2.3 million; 11 units sold versus 19 a year earlier.
- Net loss widened to $8.7 million, or $0.53 a share; included a $5.7 million valuation allowance against deferred tax assets.
- Adjusted EBITDA loss (non-GAAP) widened to $3 million from $1.8 million a year earlier.
•
